![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 10, 7897-7904, March 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Genetics and Microbiology, State
University of New York, Stony Brook, New York 11794
Received for publication, December 14, 2001
The cellular receptor for poliovirus
CD155 (or PVR) is the founding member of a new class of
membrane-associated immunoglobulin-like proteins, which include the
mouse tumor-associated antigen E4 (Tage4) and three proteins termed
"nectins." Using a yeast two-hybrid screen we have discovered that
the cytoplasmic domain of CD155 associates strongly and specifically
with Tctex-1, a light chain of the dynein motor complex, the latter
representing the major driving force for retrograde transport of
endocytic vesicles and membranous organelles. We confirmed the
interaction biochemically and by co-immunoprecipitation, and we mapped
the Tctex-1 binding site to a SKCSR motif within the juxtamembrane
region of CD155. Tctex-1 immunoreactivity was detected in mouse sciatic
nerve and spinal cord (two tissues of central importance for poliovirus pathogenesis) in punctate, possibly vesicular, patterns. We propose that the cytoplasmic domain may target CD155-containing endocytic vesicles to the microtubular network.
Neurotropic viruses like poliovirus, herpesvirus, rabies virus, and
pseudorabies virus all utilize neuronal retrograde transport to invade
the central nervous system. Association with Tctex-1 and, hence, with
the dynein motor complex may offer an explanation for how poliovirus
hijacks the cellular transport machinery to retrogradely ascend along
the axon to the neuronal cell body.
Poliovirus, a member of the genus Enterovirus of
Picornaviridae, is a human neurotropic virus that causes poliomyelitis,
a disease leading to paralysis or death. Although discovered nearly one
hundred years ago, the mechanism by which poliovirus invades the
central nervous system (CNS)1
and specifically selects motor neurons for destruction remains elusive.
Paralytic poliomyelitis is a rare neurologic complication of
poliovirus infection (one out of one hundred), as the virus enters
humans by ingestion and proliferates largely unnoticed in the
gastrointestinal tract. Interestingly, once in the CNS, the virus
spares most cells of the CNS parenchyma other than motor neurons from
destruction. This unique neurotropism has attracted attention for
decades, but no satisfactory explanation has been presented.
A major determinant of a virus' pathogenicity is its tissue tropism,
which is governed predominantly by the cognate cell surface receptor.
The receptor for all three serotypes of poliovirus, CD155 (also known
as PVR), is a membrane-associated, single-span glycoprotein belonging
to the immunoglobulin superfamily (1). The CD155 gene
expresses four splice variants of which two are membrane-bound
(CD155 Impaired by the apparently exclusive restriction to primates, CD155 is
only slowly revealing its physiological functions. CD155 mRNA
expression has been detected by Northern blot analyses in brain, small
intestine, placenta, heart, skeletal muscle, kidney, lung, and liver
(3, 4). Similar albeit not identical expression patterns have been
found in transgenic mice expressing the human CD155 gene (5,
6). CD155-tg mice are now well established as a model of
human poliomyelitis. Activity of the CD155 promoter in the
notochord and floor plate of the developing neural tube of CD155
promoter/LacZ-tg mice suggests that a primary function of CD155
may relate to the development of the CNS during embryogenesis (7).
The sites of primary infection and gastroenteric replication of
poliovirus are thought to be in tonsillopharyngeal tissue and the
Peyer's patches of the small intestine (8, 9). The commonality between
these structures is their large concentration of lymphatic cells, but,
remarkably, the predominant cells supporting poliovirus proliferation
in the gastrointestinal tract of an infected individual remain unknown.
As aforementioned, poliovirus infections are mainly restricted to the
enteric tract. Viremia, however, is a prerequisite for the progression
to poliomyelitis. How poliovirus spreads subsequently from the blood to
the CNS is poorly understood. Two pathways have been suggested. First,
the virus may directly pass from the blood into the CNS by crossing the
blood-brain barrier (10). The second hypothesis suggests that the virus
is transported by retrograde axonal transport ascending from the muscle
to the spinal cord and brain (11). This hypothesis has found strong
support in experiments with CD155-tg mice (12-14). The
presence of poliovirions in axons during poliomyelitis has been a long
observed phenomenon (15, 16). Ohka and colleagues (12) provided direct
evidence of poliovirus in the sciatic nerves of tg mice and
showed that during retrograde axonal transport the virus remains in the
form of an intact 160 S particle.
In this study we have focused on one or more possible functions of the
intracellular C-terminal domain of CD155 to decipher cell-internal
interactions important for protein function, perhaps related to
poliovirus pathogenesis. We have therefore analyzed the C-terminal
peptides of CD155 Materials
COS-1 and HEK 293, and HEK 293T cells, were maintained in
Dulbecco's modified Eagle's medium (10% fetal bovine serum and
penicillin/streptomycin). Two independently derived affinity-purified
anti-Tctex-1 polyclonal antibodies were kindly provided by S. King
(R5205, University of Connecticut, Farmingville, CT) and K. Campbell
(Fox Chase Cancer Center, Philadelphia, PA) (17, 18). Monoclonal
antibodies (mAbs) against the intermediate chain of Dynein IC74 (clone
70.1), and against alkaline phosphatase (clone 8B6) were purchased from Sigma Chemical Co. In addition, anti-CD155 mAbs D171 (19) and P44 (A. Nomoto, Tokyo University, Japan) as well as anti-mNectin2 mAb 6B3 (20)
were used in this study.
Plasmids
Plasmids were constructed using PCR and standard cloning
techniques (21). Two bait constructs for the yeast two-hybrid screen, pLexA-CD155 Yeast Two-hybrid Screen
An HeLa cell cDNA library constructed in pGAD-GH (23) was
used. The yeast tester strain L40 (24) was co-transformed with the
cDNA library and either plasmid pLexA-CD155 In Vitro Binding Experiments
GST fusion proteins were expressed and purified as previously
described (25). 35S-Labeled Tctex-1 protein was generated
from plasmid pCDNA-Tctex-1 using the coupled wheat germ in
vitro transcription/translation system (TnT by Promega) according
to the manufacturer's instructions. 100 µg of GST fusion protein
loaded to beads was incubated with 20 µl of translation product for
30 min at 30 °C, agitating the mixture every 2-3 min, followed by
four washes with binding buffer. Bound proteins were separated by
SDS-PAGE gel and visualized by autoradiography.
In a second type of GST pull-down experiment, a cytoplasmic cell lysate
of the mouse neuroblastoma cell line Neuro2A was used as a source of
endogenous Tctex-1. Neuro2A cells were lysed in cold lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 0.5% Nonidet P-40, 0.1% deoxycholate, 10%
glycerol) containing protease inhibitors. An equivalent of 5 × 106 cells was incubated with 50 µg of GST fusion protein
on beads for 3 h at 4 °C under agitation. Beads were washed
three times with lysis buffer, followed by SDS-PAGE of the eluted
proteins and Western blotting with rabbit polyclonal antibody R5205
against Tctex-1.
In a third pull-down strategy we combined the efficacy of the GST
system with the convenience of detection of AP fusion proteins. Plasmid
pCDNA-AP-CD155 Immunological Methods
Western Blotting--
For analysis of Tctex-1 protein
expression, lysates of mouse tissues from adult ICR mice were prepared
by sonification. Equal amounts of protein were separated by SDS-PAGE
and blotted onto nitrocellulose membranes (Schleicher & Schuell)
followed by Western blot analysis with anti-Tctex-1 antibodies.
Intensity of Tctex-1-immunoreactive bands on the exposed film was
determined by pixel count analysis of the scanned image with IMAGE 1.61 software (National Institutes of Health).
Co-immunoprecipitation--
HEK 293T cells were
co-transfected with CaPO4 precipitates of
plasmids pCDNA-Tctex-1 and pCDNA- CD155(AO). Three days following transfection, cells were lysed and processed as described above for
Neuro2A cells. The lysate of 5 × 106 cells was
incubated with anti-dynein (IC74) antibody 70.1, a control IgG antibody
(anti-mNectin-2, clone 6B3), or anti-CD155 antibodies (D171 and P44).
Immune complexes we captured by the addition of Protein A/G
Plus-agarose beads (Santa Cruz Biotechnologies). The precipitated
proteins were analyzed by Western blotting using anti-Tctex-1 antibodies.
Immunofluorescence--
Fresh, unfixed mouse lumbar spinal cord
and sciatic nerve tissues were frozen in O.C.T. cryoprotectant
(Tissue-Tek). E13.5 mouse embryos were fixed for 2 h in 4%
paraformaldehyde before cryoprotection. Frozen sections were collected
on poly-L-lysine-coated slides, air-dried, and fixed in
cold 1:1 methanol/acetone for 90 min at Northern Blot Analysis of Tctex-1 Expression
Multiple tissue Northern blots were purchased from
CLONTECH. The blots were hybridized at 55 °C for
16 h with 32P-labeled probes, made from a DNA fragment
containing the complete CW-1 (Tctex-1) sequence (nucleotides 1-713) by
the random primed DNA labeling system (Invitrogen).
Isolation of CD155-binding Proteins--
To identify cytoplasmic
proteins that interact with CD155, the intracellular domains of
CD155
As shown in Table I, CW-1 Is the Human Homolog to the tctex-1 Gene of the Mouse t
Complex, a Subunit of Dynein--
Sequence analysis of the clone pCW-1
revealed a fragment of ~710 bp fused to the Gal4 transcriptional
activation domain. The predicted open reading frame (ORF) was 339 nucleotides long. DNA sequences of 10 individual cDNA clones of
pCW-1 were analyzed. All cDNA clones corresponded to the same gene
(our GenBankTM accession number U56255), which upon BLAST
search was found to be highly homologous to the product of the mouse
tctex-1 (t complex testis expressed-1) gene (28). CW-1 and
mouse Tctex-1 share ~88% nucleotide identity and ~94% amino acid
identity along their respective ORFs. While this study was ongoing
Watanabe et al. (29) also cloned the human homolog of mouse
Tctex-1, identical to our sequence, and named it TCTEL1. We
will continue to use the original designation Tctex-1 for the human
protein throughout this report.
Subsequently, Tctex-1 was identified as a light-chain subunit of the
dynein motor complex (18, 30). Dynein exists in two isoforms.
Cytoplasmic dynein represents the major driving force of retrograde
transport of membrane-bound organelles and vesicles and is involved in
spindle movement during mitosis. Axonemal dynein, on the other hand, is
the force generator responsible for flagellar and ciliary beating, as
is observed in the flagella of sperm or the cilia of the respiratory
tract epithelium. Tctex-1 was found to be present in both forms of
dynein (18, 30).
Tctex-1 Expression in Mouse and Human Tissues--
Except for the
overexpression of Tctex-1 mRNA in t-haplotype mice (28), little
information is available regarding the expression profile of Tctex-1,
particularly in humans. We, therefore, performed Northern blot analysis
to determine the expression of the Tctex-1 mRNA in human tissues. A
radiolabeled DNA probe corresponding to the entire Tctex-1 cDNA
detected a single 0.75- to 0.8-kb band in all tissues tested (Fig.
3A). The highest expression of
Tctex-1 was observed in skeletal muscle and testis (Fig. 3A,
lanes 6 and 12), whereas the lowest expression
was seen in brain and thymus (lanes 2 and 10).
This expression pattern matches that observed in mouse and rat (28,
31).
Because CD155-tg mice are a widely used model for the study
of poliomyelitis, we were interested in whether tissue-specific patterns in the expression level of Tctex-1 protein reveal similarities to the patterns observed by Northern blot analyses. For this purpose we
prepared whole tissue lysates (see "Experimental Procedures") and
analyzed mouse Tctex-1 protein expression by Western blotting. Tctex-1
protein could be detected in all tissues tested, albeit at differing
amounts. Protein levels in mouse tissues largely agreed with the
mRNA expression in humans (Fig. 3). Especially the high expression
in testis (Fig. 3B, lane 7) and low expression in
CNS (lanes 1-3) and liver (lane 6) confirm
previously reported results (28, 31). However, the very high levels of
Tctex-1 mRNA expression in skeletal muscle in humans is in
disagreement with the low levels of Tctex-1 protein found in mouse
skeletal muscle (compare Fig. 3A, lane 6, and
Fig. 3B, lane 4). The reason for this discrepancy
is not known. In several tissues the anti-Tctex-1 antibodies recognized
a doublet of bands. The presence of a second band was most evident in
uterus, spleen, and kidney (Fig. 3B, lanes
9-11). Mou and coworkers (32) found Tctex-1 to be phosphorylated by the Src family kinase p59fyn.
Different phosphorylation states may therefore account for the variable
apparent size of Tctex-1. The identity of the 20-kDa band in stomach
tissue remains unknown (Fig. 3B, lane 12).
We next examined by indirect immunofluorescence the expression of
Tctex-1 in mouse tissues most relevant to poliovirus pathogenesis, sciatic nerve, and lumbar spinal cord. Using an affinity-purified rabbit polyclonal antibody (17) in combination with a Cy3-conjugated anti-rabbit secondary antibody, we detected Tctex-1 protein in both
spinal cord and sciatic nerve (Figs. 4,
and 5, respectively). Tctex-1 immune
reactivity was higher in embryonal spinal cord and dorsal root ganglia
(E13.5; Fig. 4E) when compared with the adult (Fig.
4A). This is in agreement with the developmental regulation of Tctex-1 mRNA expression in CNS and other tissues that has been described by DiBella and colleagues (33). Among a variety of neuronal
cell bodies, Tctex-1 was also expressed in the notably large motor
neurons of the anterior horn (Fig. 4C, arrows).
Tctex-1 staining was largely confined to small punctae of homogenous
size (Fig. 4C, and inset). This punctate staining
was also observed in the dorsal root where it appeared to be localized
along linear tracts, an observation suggesting that it might be
associated with sensory nerve fibers (Fig. 4D). A similar
Tctex-1 distribution was found in sciatic nerve (Fig. 5). It should be
noted that two independently derived Tctex-1 antisera, whose
specificity has been demonstrated previously (17, 18), gave identical
staining patterns (data not shown). We consider it likely that Tctex-1 may be present in transport vesicles, a conclusion supported by the
findings of the groups of Chao and Sung who independently showed the
presence of Tctex-1 in axons of cultured neurons (34) and within
synaptic vesicles at mossy fiber terminals (35).
Analysis of the CD155-Tctex-1 Interaction in Vitro--
To confirm
the interaction of CD155 with Tctex-1, we generated and expressed in
E. coli fusion proteins between glutathione S-transferase (GST) and Tctex-1 or the intracellular
C-terminal portion of CD155
To ascertain whether CD155
We then developed a different assay in which we combined
the GST system with the ease of detection of alkaline
phosphatase-tagged proteins. The cytoplasmic domain of CD155 CD155 and Tctex-1 Interact in Vivo--
To test whether an
association between CD155 and Tctex-1 could be observed in tissue
culture cells, we performed co-immunoprecipitation experiments. HEK
293T cells were co-transfected with expression plasmids for CD155 and
Tctex-1. Cell lysates were subjected to immunoprecipitation using
anti-dynein IC74 mAb 70.l (Fig. 8,
lane 2), an unrelated IgG control antibody (lane
3), or a mix of monoclonal anti-CD155 antibodies D171 and P44
(lane 4). Immune complexes were resolved by SDS-PAGE and
analyzed for Tctex-1 by Western blot analysis. As expected, antibody
70.1, directed against the intermediate chain of dynein,
co-precipitated Tctex-1 (Fig. 8, lane 2), which is a
light-chain subunit of dynein and is thought to interact directly with
the intermediate chain (31, 37). An IgG control antibody, directed
against mouse Nectin 2 (which is not expressed on human cells), did not
precipitate any Tctex-1 protein (Fig. 8, lane 3). However,
when incubated with anti-CD155 antibodies D171 and P44, Tctex-1 protein
could be precipitated from the cell lysate (Fig. 8, lane 4).
This observation indicated that CD155 and Tctex-1 also interacted
specifically in intact cells.
In this study we have described the interaction between the
cytoplasmic domain of the poliovirus receptor CD155 and Tctex-1, an
association that we originally detected in a yeast-hybrid screen. We
have presented evidence for the authenticity of this interaction by
four independent biochemical and immunological assays in
vitro and in intact cells. Our data indicate that Tctex-1
interacts with an SKCSR motif in the juxtamembrane region of the
cytoplasmic domain of CD155. We have, furthermore, presented evidence
of the presence of Tctex-1 protein in neurons of the spinal cord,
particularly motor neurons, and along fiber tracts within the dorsal
root and the sciatic nerve. The specific interaction between CD155 and Tctex-1 can serve to explain an enduring conundrum: How does poliovirus reach motor neurons, its targets in the CNS, via retrograde axonal transport?
Tctex-1 was originally identified as a candidate gene responsible for
transmission ratio distortion in male t-haplotype mice (28) and has
subsequently been shown to be a subunit of the cytoplasmic and axonemal
dynein complex (18, 38). Dynein ATPases are molecular motors that
translocate along microtubules thereby providing the driving force for
a variety of important cellular processes, most prominently the minus
end-directed (retrograde) transport of membranous vesicles and
organelles, and the motile forces necessary for flagellar and ciliary
beating (reviewed in Ref. 39). Once poliovirus infection has progressed
to viremia, two pathways are open for virus invasion into the CNS:
crossing the blood-brain barrier or retrograde axonal transport
following passage through the neuromuscular junction (NMJ).
Experimental evidence is sparse for the former but abundant for the
latter. Importantly, retrograde axonal transport has been cited as the only explanation for "provocation poliomyelitis," a phenomenon where muscle trauma may predispose an infected person to poliomyelitis (11, 13). Provocation poliomyelitis has also been suggested as the
cause for paralytic cases in a historic vaccine accident, known as the
"Cutter incidence." Here, children who received intramuscular injections of inadequately inactivated poliovirus vaccine batches developed focal limb paralysis (40). This phenomenon can be replicated
in CD155-tg mice: When injected intramuscularly with PV,
paralysis almost exclusively develops first in the limb that was
inoculated (12-14). In the 1990s, an alarming increase of oral vaccine-associated paralytic poliomyelitis was observed if vaccinees received by coincidence intramuscular injections of, for example, antibiotics or diphtheria-tetanus-pertussis vaccine (41, 42). It
was suspected that muscle injury of recipients of the Sabin oral
vaccines predisposed vaccinees to vaccine-associated paralytic poliomyelitis. Direct evidence for an increased risk of poliomyelitis following muscle injury was finally provided in experiments with CD155-tg mice (13). Considering that paralysis in most
poliomyelitis patients is found in limbs, it is intriguing to speculate
that poliovirus pathogenesis may result predominantly from retrograde axonal transport to target motor neurons followed by their destruction.
The mechanism by which muscle injury opens a portal at the NMJ to allow
virus entry into the presynaptic motor neuron is unknown. One report
describes the expression of CD155 at the NMJ, and its up-regulation in
degenerating muscle fibers (43). Such degenerating fibers would likely
be present after muscle trauma, which, in turn, could lead to increased
poliovirus replication near or at the NMJ favoring CD155 docking and
entry into the motor neuron axon. We propose that the CD155-bound virus
is then taken up at the nerve terminal into an endocytic vesicle. While
the virus remains attached to the receptor, the cytoplasmic tail of
CD155 interacts with Tctex-1, the latter mediating retrograde transport of the entire vesicle via the dynein complex to the motor neuron cell
body (Fig. 9). Indeed, our evidence of
Tctex-1 localization to small punctae within motor neurons and
peripheral nerves, reminiscent of membrane-bound organelles, (Figs. 4
and 5), would agree with such a model. This scenario requires the
presence of Tctex-1 near the presynaptic membrane where, according to
our model, virus uptake would occur. Interestingly, Chuang et
al. (35) found Tctex-1 to be concentrated in small pre-synaptic
vesicles at axon terminals of subsets of rat hippocampal neurons.
Although it has not been directly shown at the subcellular level that
Tctex-1 is expressed at motor axon terminals, Mou and colleagues (32) found the protein to be highly enriched in the eletroplax of
Torpedo californica, an organ resembling a large specialized
neuromuscular junction. Together with our evidence (Fig. 5) and that of
others (34) of Tctex-1 immune reactivity within the sciatic nerve, it
is plausible to speculate that Tctex-1 may serve a function in
retrograde transport from the motor axon terminal to the neuronal cell
body. The recent findings of Yano and colleagues (34) lend further
support to this hypothesis. This group showed that retrograde axonal
transport of neurotrophin receptors (TrkA, B, and C) within the sciatic
nerve of rats is facilitated by association of Trk with the dynein
motor complex via binding of Tctex-1 (34). Thus, neurotrophins like
nerve growth factor appear to remain linked to the dynein motor as a
receptor-ligand complex for the duration of transport from the time of
uptake at the synapse until they reach the neuronal cell body. This
mechanism seems strikingly similar to our proposed model of poliovirus
retrograde axonal transport. Sung and colleagues (44) have recently
provided convincing evidence that the Tctex-1-containing subpool of
cytoplasmic dynein is involved in apical transport of rhodopsin in
polarized epithelial cells. Apical transport in polarized cells and
retrograde axonal transport in the ultimately polarized cell, the motor
neuron, are both minus end-directed processes that are analogous in
many ways (reviewed in Ref. 45).
Interaction of the Poliovirus Receptor CD155 with the Dynein
Light Chain Tctex-1 and Its Implication for Poliovirus
Pathogenesis*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and
) and function as poliovirus receptors. CD155
and
are secreted isoforms lacking a transmembrane domain (2).
and -
in a yeast two-hybrid screen. Here we
describe the interaction of the cytoplasmic domain of CD155 with
Tctex-1, a light chain subunit of the dynein motor complex. Considering
the function of dynein as the major driving force for minus
end-directed transport along microtubuli, we propose that we have
identified a molecular link between poliovirus and the retrograde
axonal transport machinery. Indeed, we consider it possible that the
majority of poliovirus infection of the CNS leading to destruction of
motor neurons may occur via retrograde axonal transport. We discuss our
results in light of most recent findings for two other neurotropic
viruses, rabies and herpesvirus.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
or pLexA-CD155
, were generated by fusing the coding region of the cytoplasmic domains of either CD155
or CD155
to the
LexA DNA-binding domain in the vector
pTT38.2 pLexA-lam (S. Fields,
University of Washington, Seattle) contains amino acids 66-230 of
human lamin C fused to the LexA DNA-binding domain. pcDNA-Tctex-1
was generated by recovering the entire EcoRI-XhoI Tctex-1 cDNA insert of clone pCW-1 isolated in the two-hybrid screen (GenBankTM accession number U56255) and inserting it
into the pCDNA3.1 vector (Invitrogen). pCDNA-CD155(AO) (G. Bernhardt, Max-Dellbrück Center für Molekulare Medizin,
Berlin, Germany) contains the entire CD155
cDNA. For generation
of GST fusion constructs pGEX-CD155
-cyt and pGEX-Tctex-1, the
cytoplasmic domain of CD155
or the entire Tctex-1 coding region was
inserted into pGEX-KG (22). A mutant pGEX-CD155
-cm, harboring two
amino acid changes (K369T, R372L; see Fig.
1) was generated by site-directed
mutagenesis from pGEX-CD155
-cyt. For pCDNA-AP-CD155
-cyt, the
coding region of human secreted alkaline phosphatase (SEAP) was
recovered from pAPtag4 (J. Flanegan, Harvard University, Cambridge,
MA), inserted into pCDNA3.1, and fused to the cytoplasmic domain of
CD155
.

View larger version (14K):
[in a new window]
Fig. 1.
Schematic representation of the CD155
molecules. Three extracellular immunoglobulin-like domains
(circles) are formed by disulfide bonds. The transmembrane
domain (box) and the potential extracellular glycosylation
sites (N) are shown. Amino acid sequences of the cytoplasmic
domains of CD155
(CD155
-cyt), CD155
(CD155
-cyt), and a CD155
double mutant
(CD155
-cm) are listed at the
bottom. The identical amino acid sequence between
cytoplasmic domains of CD155
and CD155
are indicated by
dashes. Numbers indicate the amino acid position
with respect to the CD155
protein sequence.
or pLexA-CD155
and plated onto selection plates, lacking His, Leu, and Trp. Primary positive colonies were replated and tested for LacZ expression by
filter binding assay. Prey plasmids of
His+/LacZ+ colonies were recovered, transformed
into E. coli, and sequenced. The level of interaction of the
most strongly positive clone, pCW-1, was determined by
-galactosidase liquid assay.
-cyt or SEAP expression plasmid pAPtag4 were
transfected into HEK 293 cells. One milliliter of conditioned medium
(containing 1500A405nm/ml/h of AP fusion proteins) was incubated with 100 µg of GST fusion proteins bound to beads and agitated for 2 h at room temperature. The beads were then washed four times with PBS, and the amount of AP protein that was bound to the
beads was determined using 9 mg/ml p-nitrophenyl phosphate (in 1 M diethanolamine, pH 9.8, 0.5 mM
MgCl2) as a colorimetric substrate.
20 °C. Sections were
blocked with PBS containing 5% normal horse and 2% normal goat serum
for 2 h at room temperature, followed by overnight incubation at
4 °C with anti-Tctex-1 antibodies (17) at a dilution of 1:200 in
blocking buffer. After 2 h of washing with PBS, the sections were
incubated with a 1:500 dilution of Cy3-conjugated anti-rabbit antibody
(Jackson ImmunoResearch) for 1 h at 37 °C. The sections were
washed for 2 h in PBS and mounted with Immu-Mount (Shandon,
Pittsburgh, PA). Images were acquired on a Zeiss Axioplan II
fluorescence microscope equipped with a model SP401 camera (Diagnostic
Instruments Inc.) and processed with Adobe Photoshop software.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and CD155
were used as baits in a yeast two-hybrid
screening procedure similar to that originally described (26, 27). The
majority of His+ colonies showed LacZ activity, expressing
different levels of
-galactosidase, as assessed by filter binding
assay (data not shown). Four classes of strongly to weakly
lacZ-expressing clones were isolated. One group of most strongly
positive cDNA clones, termed pCW-1, was isolated from yeast and
co-transformed with the plasmid pLexA-CD155
or pLexA-CD155
. pCW-1
conferred resistance to His
selection only when
co-transformed with pLexA-CD155
or pLexA-CD155
but not with a
control plasmid, pLex-lam (Fig. 2).

View larger version (30K):
[in a new window]
Fig. 2.
Two-hybrid screen with cytoplasmic domains of
CD155. Yeast strain L40 (24) containing plasmid expressing the
Gal4 activation domain-Tctex-1 fusion in combination with plasmid
expressing a LexA DNA-binding domain fused to either the cytoplasmic
domain of CD155
(a), the cytoplasmic domain of CD155
(b), or the coding sequence of lamin (c).
His+, the plate that lacks only leucine and
tryptophan and thus selects only for the presence of the activation
domain and DNA-binding domain containing plasmids.
His
, the plate that lacks Leu, Trp, and His,
thus selects not only for the presence of the two plasmids but also for
the interaction of the two plasmid-encoded fusion proteins.
-galactosidase
activity was detected only in yeast in which plasmids pCW-1 and
pLexA-CD155
or pLexA-CD155
were co-expressed. There was no
activity with either Gal4 or LexA-expressing plasmids, both plasmids
together, or when co-transformed with pCW-1 and pLexA-lam. About 2000 units of
-galactosidase activity were produced when the cytoplasmic
domains of CD155 and full-length CW1 (Tctex-1, see below) were provided
(Table I). This indicated that there is a strong interaction between
the cytoplasmic domains of either CD155
or CD155
and the CW-1
fusion protein expressed in this yeast two-hybrid system.
Activation of LacZ reporter gene by Gal4 chimeras
-galactosidase activity (Miller units) are the mean of
assays on at least five transformants, each assayed at least twice.

View larger version (46K):
[in a new window]
Fig. 3.
Analysis of Tctex-1 expression in human and
mouse tissues. A, human multiple tissue Northern blot
(CLONTECH). A single band of 750-800 nucleotides
was detected by hybridization with a 32P-DNA probe
encompassing the entire Tctex-1 cDNA, which was labeled by random
priming. The sources of human RNAs are as indicated. PBL,
peripheral blood leukocytes. B, expression profile of
Tctex-1 protein in mouse tissues. Tctex-1 Western blot analysis was
performed on tissue lysates of the indicated origins. Approximately 100 µg of total protein was loaded per lane.

View larger version (148K):
[in a new window]
Fig. 4.
Localization of Tctex-1 in mouse spinal cord
by indirect immunofluorescence analysis. A,
C, D, and E represent Tctex-1 immune
reactivity using affinity-purified rabbit anti-Tctex-1 antibody (17).
B, no staining was observed with an unrelated rabbit
preimmune serum. A and B, adult spinal cord
(right hemichord). Note: Each image is a composite of two frames taken
with a ×10 objective. C, higher magnification of
boxed area in A. Two motor neurons are marked by
arrows. The inset depicts a motor neuron with
Tctex-1 immune reactivity localizing to small punctae. D,
adult dorsal root at the region of the dorsal root entry zone. Tctex-1
punctate staining is found concentrated along linear tracts.
E, embryonic spinal cord and dorsal root ganglia (E13.5).
VH, ventral horn; DH, dorasl horn; MN,
motor neuron; DRG, dorsal root ganglion. Scale
bars: A, B, and E, 200 µm;
C, 100 µm; C (inset) and
D, 20 µm.

View larger version (65K):
[in a new window]
Fig. 5.
Localization of Tctex-1 in mouse sciatic
nerve. A-C, longitudinal sections of adult mouse
sciatic nerve. A, Tctex-1 immunoreactivity is found
throughout the sciatic nerve, in patterns reminiscent of fiber tracts.
B, higher magnification of boxed area in
A. C, no staining was observed with an unrelated
rabbit preimmune serum. Scale bars: A and
C, 200 µm; B, 100 µm.
(GST-CD155
-cyt, Fig.
6A). In a first set of experiments, the GST fusion proteins, bound to glutathione-Sepharose beads, were then used in a GST pull-down assay (36) to determine affinities to in vitro translated 35S-Tctex-1.
GST-CD155
-cyt specifically bound Tctex-1 (Fig. 6B, lane 4), whereas GST alone did not interact with Tctex-1
(lane 2). We also noticed a weak homo-interaction of Tctex-1
with GST-Tctex-1 (lane 3), an observation supporting a
recent report by DiBella and co-workers (33) who demonstrated that
Tctex-1 may form a homodimer within the dynein complex.

View larger version (50K):
[in a new window]
Fig. 6.
CD155/Tctex-1 interaction demonstrated by GST
pull-down assay. A, SDS-PAGE analysis of purified GST
fusion proteins (Coomassie Blue-stained). Lane 1, GST;
lane 2; Tctex-1 fused to GST; lane 3, K369T/R372L
double mutant of CD155
fused to GST; lane 4, wild type
cytoplasmic domain of CD155
fused to GST. B, GST
pull-down of radiolabeled Tctex-1 protein, synthesized by in
vitro translation. GST fusion proteins bound to glutathione beads
were incubated with 20 µl of in vitro translated Tctex-1.
The beads were analyzed for specifically bound Tctex-1 by SDS-PAGE
followed by autoradiography. Lane 1, 5 µl of Tctex-1
in vitro translation reaction; lanes 2-4,
Tctex-1 protein recovered by binding to GST fusion proteins, as
indicated. C, GST pull-down of endogenous Tctex-1. Mouse
Neuro2A cell lysates were incubated with the indicated GST fusion
proteins or empty glutathione beads. Proteins bound to the beads were
separated by SDS-PAGE and analyzed by Tctex-1 Western blot
(middle panel). The intensities of Tctex-1-immunoreactive
bands on the image of the scanned x-ray film were determined using the
National Institutes of Health IMAGE software (lower panel).
The numbers represent a pixel count for each lane. The top
portion of the same gel was Coomassie-stained as a loading control
for the GST fusion proteins (top panel).
could also interact with endogenous
Tctex-1 present in neuronal cells, we extended the GST pull-down experiments and replaced Tctex-1 radiolabeled by in vitro
translation with Tctex-1 from cytoplasmic lysates of mouse Neuro2A
cells (Fig. 6C). The material bound to the glutathione beads
was analyzed for the presence of Tctex-1 protein by immunoblotting. As
is apparent in Fig. 6C, CD155
strongly interacted with
cellular Tctex-1 (middle panel, lane 5). Neither
glutathione beads alone, nor GST complexed to glutathione beads,
interacted with endogenous Tctex-1 under the conditions of the assay
(lanes 2 and 3, respectively). Because both
membrane-bound splice variants of CD155, CD155
, and CD155
, interacted with Tctex-1 in the two-hybrid system, we suspected that the
target sequence for Tctex-1 binding lay within the 17 N-terminal
cytoplasmic residues that both splice variants have in common (see Fig.
1B). Mok and colleagues (37) have proposed the sequence
(R/K)(R/K)XX(R/K) as a Tctex-1 consensus recognition motif . The N-terminal portions of both CD155 cytoplasmic domains contain the sequence SKCSR, which partly matches this motif (Fig. 1B). We therefore produced a CD155
mutant protein
(CD155
-cm) in which the SKCSR sequence
was changed to STCSL (bold residues represent
those that have been mutated. Binding of CD155
-cm to
Tctex-1 was reduced by more than 10-fold when compared with the wild
type protein (Fig. 6, middle panel, compare lanes
4 and 5). This observation strongly suggests that the
SKCSR sequence, indeed, is critical for the interaction between CD155 and Tctex-1.
was
fused to the C terminus of human placental secreted alkaline
phosphatase (AP-CD155
-cyt, Fig.
7A). AP-CD155
-cyt fusion
protein and untagged AP protein were expressed in HEK 293 cells from
which they were secreted into the culture medium of the cells. After 5 days of expression the medium contained ~1500
A405 nm/ml/h of alkaline phosphatase activity,
as assessed by a colorimetric assay using p-nitrophenyl phosphate as a substrate for alkaline phosphatase (see "Experimental Procedures"). To confirm the integrity of the secreted proteins, we
immunoprecipitated the AP proteins from the supernatant with an
alkaline phosphatase-specific antibody and analyzed the immune complexes by Western blot using the same antibody (Fig. 7B).
As expected, AP-CD155
-cyt appeared to be slightly larger than AP, due to the addition of 50 amino acids comprising the cytoplasmic domain
of CD155
(Fig. 7B, lane 2). The secreted AP
and AP-CD155
-cyt were then incubated with glutathione beads to which
GST fusion proteins were bound. Although none of the GST fusion
proteins bound any significant amount of untagged AP protein (Fig. 7,
bars 2, 4, 6), GST-Tctex-1-loaded
beads specifically captured AP-CD155
-cyt from the medium (bar
1). No interaction was seen between AP-CD155
-cyt and GST alone
(bar 5). Finally, under the conditions of the assay, there
was also no homo-interaction observed between CD155 cytoplasmic tails,
because we detected no signal after incubation of AP-CD155
-cyt with
GST-CD155
-cyt (bar 3).

View larger version (19K):
[in a new window]
Fig. 7.
Tctex-1 interaction with a CD155-alkaline
phosphatase fusion protein. A, the cytoplasmic domain
of CD155
was fused to the SEAP ORF, to produce AP-CD155
-cyt.
B, AP and AP-CD155
-cyt proteins were expressed in HEK 293 cells and secreted into the culture medium. Immunoprecipitation of 0.5 ml of conditioned culture medium with alkaline phosphatase-specific
antibodies followed by anti-alkaline phosphatase Western blotting
produced single immune-reactive bands of 67 and 71 kDa, respectively
(lanes 1 and 2). C, the supernatants
containing the expressed proteins were used as probes for GST
pull-down. If an interaction occurred, alkaline phosphatase activity
could be recovered from the glutathione beads. The amount of bound AP
fusion protein was assayed in a colorimetric assay using
p-nitrophenyl phosphate as a substrate. Absorbance was read
at 405 nm.

View larger version (46K):
[in a new window]
Fig. 8.
Co-immunoprecipitation of CD155 and
Tctex-1. HEK 293T cells were co-transfected with expression
plasmids for full-length CD155 and Tctex-1. Cell lysates were incubated
with precipitating antibodies as indicated. The co-immunoprecipitate
was recovered by protein A/G beads and analyzed by 13.5% SDS-PAGE
followed by anti Tctex-1 Western blot. Lane 1, cell lysate;
lane 2, immunoprecipitation (IP) with anti-dynein
IC74 mAb; lane 3, IP with an unrelated IgG mAb; lane
4, IP with anti-CD155 mAbs D171/P44. The protein band
corresponding to Tctex-1 protein is marked by an
arrow.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (45K):
[in a new window]
Fig. 9.
Proposed model of CNS invasion by
poliovirus. 1, following virus replication in muscle,
virions are released near or at the NMJ, and taken up at the
presynaptic membrane of a motor axon by CD155-mediated endocytosis.
Muscle injury or inflammatory responses due to the PV infection may
facilitate this process by up-regulation of CD155 expression. The
virus-receptor complex by interaction with Ttcex-1 is
targeted to the microtubular network of the axon. 2, the
intact 160S virions complexed to the dynein motor by virtue of CD155
interaction with Tctex-1 are transported along microtubuli by fast
retrograde axonal transport. 3, arriving at the motor
neuron's cell body, the change in environment from axoplasm to
cytoplasm triggers virus uncoating. Viral genomic RNA is released into
the cytoplasm, and virus replication ensues, thereby killing the motor
neuron. Paralysis of the muscle fiber formerly innervated by this motor
neurons follows. Lateral spreading to neighboring spinal motor neurons
may occur, which kills those neurons directly and independently of
retrograde axonal transport.
It is interesting to note that structural proteins of other neurotropic viruses (herpes, rabies, and Mokola virus) have recently been reported to interact with components of the dynein motor complex (46-48). More intriguing yet is the fact that herpesviruses use as their cellular receptors Nectin-1 and -2, two molecules of the CD155 family of immunoglobulin-like proteins (49, 50). Most promiscuous in terms of receptors is pseudorabies virus (PRV), an animal herpesvirus that can use Nectin-1, Nectin-2, as well as CD155 for cell entry (49, 50). PRV is being used widely as a transneuronal tracer in neuroanatomical studies by virtue of monitoring its retrograde travel from the site of injection along axonal pathways of neurons (51, 52). The P protein of rabies and Mokola virus has been found to bind to the dynein light-chain polypeptide LC8 (46, 47). Indeed, CD155 as well as acetylcholine receptor, a putative receptor for rabies virus, are expressed at the NMJ (43, 53). Just as in provocation poliomyelitis, rabies virus pathogenesis is mostly preceded by muscle trauma (here, the bite of a rabid animal) with subsequent virus entry into axons and retrograde transport to neuronal targets (54).
It appears that the underlying mechanisms of CNS invasion for all three
groups of viruses, poliovirus, lyssaviruses (e.g. rabies),
and herpesviruses (herpes simplex virus, PRV), are similar by
hijacking the dynein machinery for retrograde travel to target neurons.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Drs. Steve King, Kerry Campbell, Akio Nomoto, and Günter Bernhardt for antibodies and plasmids. We are indebted to Meijia Yang and Stan Fields for valuable discussion and suggestions as well as for providing us the materials of yeast two-hybrid system.
| |
FOOTNOTES |
|---|
* This work was supported in part by Public Health Service Grants A1-15122 and R01AT-32100 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a doctoral fellowship of Boehringer Ingelheim Fonds,
Heidesheim, Germany.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) U56255.
§ Current address: Pfizer Global Research & Development, Groton, CT 06340.
¶ To whom correspondence should be addressed: Dept. of Molecular Genetics and Microbiology, State University of New York, Stony Brook, NY 11794. Tel.: 631-632-8787; Fax: 631-632-8891; E-mail: ewimmer@ms.cc.sunysb.ed.
Published, JBC Papers in Press, December 21, 2001, DOI 10.1074/jbc.M111937200
2 M. Yang, unpublished.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: CNS, central nervous system; mAb, monoclonal antibody; GST, glutathione S-transferase; AP, alkaline phosphatase; SEAP, secreted alkaline phosphatase; ORF, open reading frame; NMJ, neuromuscular junction; PRV, pseudorabies virus.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Mendelsohn, C. L., Wimmer, E., and Racaniello, V. R. (1989) Cell 56, 855-865[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Koike, S., Horie, H., Ise, I., Okitsu, A., Yoshida, M., Iizuka, N., Takeuchi, K., Takegami, T., and Nomoto, A. (1990) EMBO J. 9, 3217-3224[Medline] [Order article via Infotrieve] |
| 3. |
Ren, R.,
and Racaniello, V. R.
(1992)
J. Virol.
66,
296-304 |
| 4. | Koike, S., Aoki, J., and Nomoto, A. (1994) in Cellular Receptors for Animal Viruses (Wimmer, E., ed) , pp. 463-480, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 5. |
Koike, S.,
Taya, C.,
Kurata, T.,
Abe, S.,
Ise, I.,
Yonekawa, H.,
and Nomoto, A.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
951-955 |
| 6. | Ren, R., Costantini, F., Gorgacz, E. J., Lee, J. J., and Racaniello, V. R. (1990) Cell 63, 353-362[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Gromeier, M., Solecki, D., Patel, D. D., and Wimmer, E. (2000) Virology 273, 248-257[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Bodian, D. (1956) Am. J. Hyg. 64, 181-197[Medline] [Order article via Infotrieve] |
| 9. | Sabin, A., and Ward, R. (1941) J. Exp. Med. 73, 757-770[Abstract] |
| 10. | Yang, W. X., Terasaki, T., Shiroki, K., Ohka, S., Aoki, J., Tanabe, S., Nomura, T., Terada, E., Sugiyama, Y., and Nomoto, A. (1997) Virology 229, 421-428[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | McCloskey, B. P. (1950) Lancet 1, 659-663[CrossRef] |
| 12. | Ohka, S., Yang, W. X., Terada, E., Iwasaki, K., and Nomoto, A. (1998) Virology 250, 67-75[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Gromeier, M.,
and Wimmer, E.
(1998)
J. Virol.
72,
5056-5060 |
| 14. | Ren, R., and Racaniello, V. R. (1992) J. Infect. Dis. 166, 747-752[Medline] [Order article via Infotrieve] |
| 15. |
Bodian, D.
(1940)
Brain
63,
135-177 |
| 16. | Fairbrother, R. W., and Hurst, E. W. (1930) J. Pathol. Bacteriol. 33, 17-45[CrossRef] |
| 17. |
Campbell, K. S.,
Cooper, S.,
Dessing, M.,
Yates, S.,
and Buder, A.
(1998)
J. Immunol.
161,
1728-1737 |
| 18. |
King, S. M.,
Dillman, J. F., 3rd,
Benashski, S. E.,
Lye, R. J.,
Patel-King, R. S.,
and Pfister, K. K.
(1996)
J. Biol. Chem.
271,
32281-32287 |
| 19. |
Nobis, P.,
Zibirre, R.,
Meyer, G.,
Kuhne, J.,
Warnecke, G.,
and Koch, G.
(1985)
J. Gen. Virol.
66,
2563-2569 |
| 20. | Aoki, J., Koike, S., Asou, H., Ise, I., Suwa, H., Tanaka, T., Miyasaka, M., and Nomoto, A. (1997) Exp. Cell Res. 235, 374-384[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd. Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 22. | Guan, K. L., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Hannon, G. J.,
Demetrick, D.,
and Beach, D.
(1993)
Genes Dev.
7,
2378-2391 |
| 24. | Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74, 205-214[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Cuconati, A.,
Xiang, W.,
Lahser, F.,
Pfister, T.,
and Wimmer, E.
(1998)
J. Virol.
72,
1297-1307 |
| 26. |
Chien, C. T.,
Bartel, P. L.,
Sternglanz, R.,
and Fields, S.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
9578-9582 |
| 27. | Fields, S., and Song, O. (1989) Nature 340, 245-246[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Lader, E., Ha, H. S., O'Neill, M., Artzt, K., and Bennett, D. (1989) Cell 58, 969-979[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Watanabe, T. K., Fujiwara, T., Shimizu, F., Okuno, S., Suzuki, M., Takahashi, E., Nakamura, Y., and Hirai, Y. (1996) Cytogenet. Cell Genet. 73, 153-156[Medline] [Order article via Infotrieve] |
| 30. |
Harrison, A.,
Olds-Clarke, P.,
and King, S. M.
(1998)
J. Cell Biol.
140,
1137-1147 |
| 31. | King, S. M., Barbarese, E., Dillman, J. F., 3rd, Benashski, S. E., Do, K. T., Patel-King, R. S., and Pfister, K. K. (1998) Biochemistry 37, 15033-15041[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Mou, T., Kraas, J. R., Fung, E. T., and Swope, S. L. (1998) FEBS Lett. 435, 275-281[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
DiBella, L. M.,
Benashski, S. E.,
Tedford, H. W.,
Harrison, A.,
Patel-King, R. S.,
and King, S. M.
(2001)
J. Biol. Chem.
276,
14366-14373 |
| 34. | Yano, H., Lee, F. S., Kong, H., Chuang, J., Arevalo, J., Perez, P., Sung, C., and Chao, M. V. (2001) J. Neurosci. 21, RC125 |
| 35. |
Chuang, J. Z.,
Milner, T. A.,
and Sung, C. H.
(2001)
J. Neurosci.
21,
5501-5512 |
| 36. | Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (1998) Current Protocols in Molecular Biology , John Wiley & Sons, New York |
| 37. |
Mok, Y. K., Lo, K. W.,
and Zhang, M.
(2001)
J. Biol. Chem.
276,
14067-14074 |
| 38. | Kagami, O., Gotoh, M., Makino, Y., Mohri, H., Kamiya, R., and Ogawa, K. (1998) Gene 211, 383-386[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Holzbaur, E. L., and Vallee, R. B. (1994) Annu. Rev. Cell Biol. 10, 339-372[CrossRef] |
| 40. | Nathanson, N., and Langmuir, A. D. (1963) Am. J. Hyg. 78, 61-81 |
| 41. | Sutter, R. W., Patriarca, P. A., Suleiman, A. J., Brogan, S., Malankar, P. G., Cochi, S. L., Al-, Ghassani, A. A., and el-Bualy, M. S. (1992) J. Infect. Dis. 165, 444-449[Medline] [Order article via Infotrieve] |
| 42. |
Strebel, P. M.,
Ion-Nedelcu, N.,
Baughman, A. L.,
Sutter, R. W.,
and Cochi, S. L.
(1995)
N. Engl. J. Med.
332,
500-506 |
| 43. | Leon-Monzon, M. E., Illa, I., and Dalakas, M. C. (1995) Ann. N. Y. Acad. Sci. 753, 48-57[Abstract] |
| 44. |
Tai, A. W.,
Chuang, J. Z.,
and Sung, C. H.
(2001)
J. Cell Biol.
153,
1499-1509 |
| 45. | Goldstein, L. S., and Yang, Z. (2000) Annu. Rev. Neurosci. 23, 39-71[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Raux, H.,
Flamand, A.,
and Blondel, D.
(2000)
J. Virol.
74,
10212-10216 |
| 47. |
Jacob, Y.,
Badrane, H.,
Ceccaldi, P. E.,
and Tordo, N.
(2000)
J. Virol.
74,
10217-10222 |
| 48. |
Ye, G. J.,
and Roizman, B.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11002-11007 |
| 49. |
Geraghty, R. J.,
Krummenacher, C.,
Cohen, G. H.,
Eisenberg, R. J.,
and Spear, P. G.
(1998)
Science
280,
1618-1620 |
| 50. | Warner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I., Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H., and Spear, P. G. (1998) Virology 246, 179-189[CrossRef][Medline] [Order article via Infotrieve] |
| 51. | Strack, A. M., Sawyer, W. B., Hughes, J. H., Platt, K. B., and Loewy, A. D. (1989) Brain Res. 491, 156-162[CrossRef][Medline] [Order article via Infotrieve] |
| 52. | Loewy, A. D. (1995) in Viral Vectors (Kaplitt, G. , and Loewy, A. D., eds) , pp. 349-366, Academic Press, San Diego |
| 53. |
Lentz, T. L.,
Burrage, T. G.,
Smith, A. L.,
Crick, J.,
and Tignor, G. H.
(1982)
Science
215,
182-184 |
| 54. | Murphy, F. A., and Bauer, S. P. (1974) Intervirology 3, 256-268[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
|